JavaScript is disabled for your browser. Some features of this site may not work without it.
Estadísticas
Número total de visitas
| Vistas | |
|---|---|
| A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study | 60 |
Visitas al mes
| febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | |
|---|---|---|---|---|---|---|---|
| A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study | 1 | 3 | 1 | 2 | 2 | 7 | 4 |
Países con más visualizaciones
| Vistas |
|---|
Ciudades con más visualizaciones
| Vistas |
|---|
